Your browser doesn't support javascript.
loading
The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia.
Mladenov, Radoslav; Hristodorov, Dmitrij; Cremer, Christian; Hein, Lea; Kreutzer, Fabian; Stroisch, Tim; Niesen, Judith; Brehm, Hannes; Blume, Tobias; Brümmendorf, Tim Henrik; Jost, Edgar; Thepen, Theophilus; Fischer, Rainer; Stockmeyer, Bernhard; Barth, Stefan; Stein, Christoph.
Afiliação
  • Mladenov R; Department of Experimental Medicine and Immunotherapy, Institute for Applied Medical Engineering, RWTH Aachen University Clinic, Aachen, Germany.
  • Hristodorov D; Department of Pharmaceutical Product Development, Fraunhofer Institute for Molecular Biology and Applied Ecology, Aachen, Germany.
  • Cremer C; Department of Experimental Medicine and Immunotherapy, Institute for Applied Medical Engineering, RWTH Aachen University Clinic, Aachen, Germany.
  • Hein L; Department of Pharmaceutical Product Development, Fraunhofer Institute for Molecular Biology and Applied Ecology, Aachen, Germany.
  • Kreutzer F; Department of Experimental Medicine and Immunotherapy, Institute for Applied Medical Engineering, RWTH Aachen University Clinic, Aachen, Germany.
  • Stroisch T; Department of Experimental Medicine and Immunotherapy, Institute for Applied Medical Engineering, RWTH Aachen University Clinic, Aachen, Germany.
  • Niesen J; Department of Experimental Medicine and Immunotherapy, Institute for Applied Medical Engineering, RWTH Aachen University Clinic, Aachen, Germany.
  • Brehm H; Department of Experimental Medicine and Immunotherapy, Institute for Applied Medical Engineering, RWTH Aachen University Clinic, Aachen, Germany.
  • Blume T; Department of Pharmaceutical Product Development, Fraunhofer Institute for Molecular Biology and Applied Ecology, Aachen, Germany.
  • Brümmendorf TH; Department of Experimental Medicine and Immunotherapy, Institute for Applied Medical Engineering, RWTH Aachen University Clinic, Aachen, Germany.
  • Jost E; Department of Experimental Medicine and Immunotherapy, Institute for Applied Medical Engineering, RWTH Aachen University Clinic, Aachen, Germany.
  • Thepen T; Department of Hematology and Oncology (Internal Medicine IV), RWTH Aachen University Hospital, Aachen, Germany.
  • Fischer R; Department of Hematology and Oncology (Internal Medicine IV), RWTH Aachen University Hospital, Aachen, Germany.
  • Stockmeyer B; Department of Pharmaceutical Product Development, Fraunhofer Institute for Molecular Biology and Applied Ecology, Aachen, Germany.
  • Barth S; Department of Pharmaceutical Product Development, Fraunhofer Institute for Molecular Biology and Applied Ecology, Aachen, Germany.
  • Stein C; Department of Internal Medicine 5 Hematology/Oncology, University of Erlangen-Nuremberg, Erlangen, Germany.
Int J Cancer ; 137(11): 2729-38, 2015 Dec 01.
Article em En | MEDLINE | ID: mdl-26041304
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Fc / Leucemia Mieloide / Antígenos CD / Antígenos de Neoplasias Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Fc / Leucemia Mieloide / Antígenos CD / Antígenos de Neoplasias Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha